JUL 11, 2014 12:00 AM PDT

Weight Loss Is Critical in Reducing Cardiovascular Risk for Patients with Obstructive Sleep Apnea

WRITTEN BY: Ilene Schneider
Obesity and obstructive sleep apnea (OSA) can increase cardiovascular risk factors, including inflammation, insulin resistance, abnormal cholesterol and high blood pressure. While effective therapies are available for OSA, researchers are still unclear about what interventions are most effective in reducing the burden of risk factors for cardiovascular disease associated with OSA in obese patients. New research from a multidisciplinary team at the Perelman School of Medicine at the University of Pennsylvania now reveals that the single most important factor for improving cardiovascular health in obese OSA patients is weight loss. The study results are published in the New England Journal of Medicine.

"In the U.S. almost 1 in 5 adults has sleep apnea, which is associated with an increased risk for a variety of cardiovascular complications. Sleep apnea and obesity are strongly associated with each other. We performed this study to find out to what degree obesity and OSA contribute to the burden of cardiovascular risk factors and to quantify the reduction in these risk factors achieved by weight loss, therapy for sleep apnea, or the combination of both" said lead study author Julio Chirinos, MD,PhD, assistant professor of Medicine at Penn.

In the trial, the investigators randomly assigned 181 participants with obesity, moderate-to-severe obstructive sleep apnea and high C-reactive protein levels (CRP) -- an inflammatory marker associated with heart disease -- for 24 weeks to either weight loss therapy, CPAP therapy or the combination of weight loss and CPAP. The authors then evaluated the incremental effect of combination therapy with CPAP and weight loss over each therapy alone, on subclinical inflammation, insulin resistance, dyslipidemia and blood pressure in obese subjects with OSA.

The investigators found no significant effect of combination therapy over either therapy alone when it came to reducing CRP levels. Weight loss alone significantly reduced CRP, insulin resistance, dyslipidemia and high blood pressure. In stark contrast, they did not observe a significant effect of CPAP on CRP, insulin sensitivity or dyslipidemia, even among subjects who adhered to therapy. "These data argue against an independent causal relationship between obstructive sleep apnea and these cardiovascular risk factors in this population and suggest that CPAP is not an effective therapy to reduce the burden of these particular risk factors. These findings also indicate that weight loss therapy should be a central component of strategies to improve the cardiovascular risk factor profile of obese patients with OSA," said Chirinos.

Despite the lack of an effect of CPAP therapy on the risk factors mentioned above, both CPAP and weight loss reduced blood pressure. Furthermore, among subjects who adhered to therapy, CPAP provided an incremental effect over weight loss-only (i.e., participants randomized to combination therapy had a more pronounced effect on blood pressure than participants receiving either therapy alone). "The design of this trial allowed us to conclude that both obesity and sleep apnea are causally related to high blood pressure," Chirinos added.

In addition, the results suggest that adhering to a regimen of weight loss and CPAP therapy will result in larger reductions in blood pressure as compared with either therapy alone.

The study opens several questions for future research. "Effective weight reduction interventions as applied in our study are costly and require a multidisciplinary team with expertise in weight loss. Future research should assess how to best deliver effective weight loss programs for these patients. In addition, more research on strategies to enhance CPAP adherence or to identify subjects that are most likely to demonstrate an important reduction in blood pressure with CPAP would be desirable," said Chirinos.

Other study authors from Penn include Indira Gurubhagavatula, MD, Daniel J. Rader, MD, Thomas Wadden, PhD, Raymond Townsend, MD, Greg Maislin, MS, Hassam Saif, MD, Jesse Chittam, MS, Preston Broderick, Alexandra L. Hanlon, PhD and Allan Pack, MD. The study was supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) (R01080076 and P01 HL094307).
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JUL 07, 2020
Cardiology
Investigating New Ways to Diagnose a Heart of Bone
JUL 07, 2020
Investigating New Ways to Diagnose a Heart of Bone
Calcific aortic stenosis, or calcific aortic valve disease (CAVD), is a progressive cardiovascular disease where the aor ...
AUG 08, 2020
Cardiology
Identifying Connections Between Rheumatoid Arthritis and Cardiovascular Health
AUG 08, 2020
Identifying Connections Between Rheumatoid Arthritis and Cardiovascular Health
Most people recognize rheumatoid arthritis as a disease that weakens the joints. It is actually an autoimmune disease, w ...
SEP 10, 2020
Cardiology
Many Doctors Have Used the Wrong Criteria to Diagnose Hypertension
SEP 10, 2020
Many Doctors Have Used the Wrong Criteria to Diagnose Hypertension
A recent survey has shown that most health care professionals may not be using the current information to screen for and ...
SEP 21, 2020
Clinical & Molecular DX
Smart Wearable Patch Signals Trouble Following Traumatic Injury
SEP 21, 2020
Smart Wearable Patch Signals Trouble Following Traumatic Injury
An ambulance pulls up to the site of a car accident, sirens blazing. Paramedics assess the crash victims, looking for si ...
NOV 01, 2020
Neuroscience
Depression Increases Risk of Having a Stroke
NOV 01, 2020
Depression Increases Risk of Having a Stroke
Researchers in Alabama have found that people who suffer from multiple depressive symptoms are at an increased risk of h ...
NOV 17, 2020
Cardiology
Validating Blood Pressure Functionality in a New Smartwatch
NOV 17, 2020
Validating Blood Pressure Functionality in a New Smartwatch
One of the most exciting advancements in our time is wearable technology. While most see it as a cool piece of tech on y ...
Loading Comments...